Dr. Reddys Laboratories Ltd.

Further to the intimation dated February 19, 2018 regarding US Securities Class Action Lawsuit, Dr. Reddys Laboratories has informed that on March 21, 2019 the United States District Court for the District of New Jersey issued its decision (dated March 20, 2019) granting in part and denying in part its Motion to Dismiss. The Court has dismissed Plaintiff's claims with respect to 17 out of the 22 alleged misstatements. As intimated earlier, the Company believes that the remaining alleged claims of misstatements are without merit and intends to vigorously defend itself against them.

The above information is a part of company’s filings submitted to BSE.